🇺🇸 anti-emetics in United States

30 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 30

Most-reported reactions

1. Neutropenia — 5 reports (16.67%)
2. Nausea — 4 reports (13.33%)
3. Pyrexia — 4 reports (13.33%)
4. Vomiting — 4 reports (13.33%)
5. Pain — 3 reports (10%)
6. Abdominal Pain — 2 reports (6.67%)
7. Cholecystitis — 2 reports (6.67%)
8. Cholelithiasis — 2 reports (6.67%)
9. Dehydration — 2 reports (6.67%)
10. Diarrhoea — 2 reports (6.67%)

Source database →

Frequently asked questions

Is anti-emetics approved in United States?

anti-emetics does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for anti-emetics in United States?

Pediatric Brain Tumor Consortium is the originator. The local marketing authorisation holder may differ — check the official source linked above.